ArticleJTO clinical and research reports2026

Brief Report: Real-World Comparative Effectiveness of First-Line Immune Checkpoint Inhibitor Monotherapy Versus Chemo-Immunotherapy in Metastatic NSCLC With PD-L1 More Than or Equal to 50%: A Meta-Analysis.

Thierry Landre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.